In-depth interviews about current ideas and innovation in medicine, science, and clinical practice.
Gregory Armstrong, MD, director of the Advanced Molecular Detection Program for the CDC, explains what is currently known about the new mutations of SARS-CoV-2.
Related Article(s): Genetic Variants of SARS-CoV-2—What Do They Mean?
Next-Generation Sequencing of Infectious Pathogens
Next Generation Sequencing of Infectious Pathogens in Public Health and Clinical Practice
Understanding SARS-CoV-2 Genetic Variants